Hypersensitivity  >>  pimecrolimus topical  >>  Phase 4
Welcome,         Profile    Billing    Logout  

10 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pimecrolimus topical / Generic mfg.
NCT00666159: Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Treating Pediatric Patients With Atopic Dermatitis

Completed
4
226
US
tacrolimus ointment, Protopic, FK506 ointment, pimecrolimus cream, Elidel
Astellas Pharma Inc
Dermatitis, Atopic
05/03
05/03
NCT00666302: A Comparison Study Between Protopic (Tacrolimus) Ointment and Elidel (Pimecrolimus) Cream in Treating Subjects With Atopic Dermatitis

Completed
4
413
US, Canada
tacrolimus ointment, Protopic, FK506 ointment, pimecrolimus cream, Elidel
Astellas Pharma Inc
Dermatitis, Atopic
11/03
11/03
NCT00667160: Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Pediatric Patients With Mild Atopic Dermatitis

Completed
4
426
US
tacrolimus ointment, Protopic, FK506 ointment, pimecrolimus cream, Elidel
Astellas Pharma Inc
Dermatitis, Atopic
11/03
11/03
NCT00119158: Combination Therapy for Atopic Dermatitis

Completed
4
90
US
Combination of pimecrolimus and fluticasone, Pimecrolimus cream, fluticasone, pimecrolimus
Children's Hospital of Philadelphia, Novartis Pharmaceuticals
Atopic Dermatitis
06/05
06/05
NCT00925730: Open-label Study to Investigate Systemic Exposure in Adult and Pediatric Atopic Dermatitis Patients Treated 8.5 Days With Pimecrolimus Cream 1% Under Occlusion

Completed
4
20
Europe
Pimecrolimus
Novartis
Atopic Dermatitis
01/06
 
NCT00510003 / 2004-001273-26: Assessment of Pruritus Improvement With Pimecrolimus Treatment on the Areas Affected by Mild-to-moderate AD, in Patients 2- to 11- Year-old

Completed
4
117
Europe
Pimecrolimus, Elidel
Novartis Pharmaceuticals
Atopic Dermatitis
01/06
 
NCT00509990 / 2017-001766-25: Open Label Study of Long Term Treatment of Pediatric Treatment of Atopic Dermatitis With Pimecrolimus Cream 1% Within a Usual Clinical Setting

Completed
4
200
RoW
Pimecrolimus, Elidel
Novartis Pharmaceuticals
Atopic Dermatitis
09/07
 
NCT00367393 / 2005-004259-37: Reconstitution With Pimecrolimus Cream 1% of Steroid-damaged Skin in Adults With Atopic Dermatitis

Completed
4
41
Europe
Pimecrolimus cream 1%, ASM981
Novartis
Atopic Dermatitis
12/07
12/07
NCT00124709 / 2017-001765-25: Safety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease Modification

Terminated
4
1091
US
Pimecrolimus, Elidel, Corticosteroid
Novartis Pharmaceuticals
Atopic Dermatitis
01/08
11/08
NCT00568412 / 2007-002133-36: A Clinical Study in Children and Adolescents With Mild to Moderate Atopic Dermatitis

Completed
4
80
Europe
Zarzenda, Elidel
Bayer
Mild to Moderate Atopic Dermatitis
09/08
09/08

Download Options